Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada’s Sentinel Physician Surveillance Network, January 2015

Impact of Repeated Vaccination on Vaccine Effectiveness Against Influenza A(H3N2) and B During 8 Seasons

(2014) Huong Q. McLean et al.   CLINICAL INFECTIOUS DISEASES

Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis

(2014) J Castilla et al.   Eurosurveillance

Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada’s sentinel surveillance network, January 2014

(2014) D Skowronski et al.   Eurosurveillance

Influenza A/Subtype and B/Lineage Effectiveness Estimates for the 2011–2012 Trivalent Vaccine: Cross-Season and Cross-Lineage Protection With Unchanged Vaccine

(2014) Danuta M. Skowronski et al.   JOURNAL OF INFECTIOUS DISEASES

Influenza Vaccine Effectiveness in Households With Children During the 2012-2013 Season: Assessments of Prior Vaccination and Serologic Susceptibility

(2014) S. E. Ohmit et al.   JOURNAL OF INFECTIOUS DISEASES

Low 2012–13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses

(2014) Danuta M. Skowronski et al.   PLoS One

Playing Hide and Seek: How Glycosylation of the Influenza Virus Hemagglutinin Can Modulate the Immune Response to Infection

(2014) Michelle Tate et al.   Viruses-Basel

Influenza Vaccine Effectiveness in the 2011–2012 Season: Protection Against Each Circulating Virus and the Effect of Prior Vaccination on Estimates

(2013) Suzanne E. Ohmit et al.   CLINICAL INFECTIOUS DISEASES

Influenza Vaccine Effectiveness in the Community and the Household

(2013) S. E. Ohmit et al.   CLINICAL INFECTIOUS DISEASES

The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials

(2013) G De Serres et al.   Eurosurveillance

Substitutions Near the Receptor Binding Site Determine Major Antigenic Change During Influenza Virus Evolution

(2013) B. F. Koel et al.   SCIENCE

A Sentinel Platform to Evaluate Influenza Vaccine Effectiveness and New Variant Circulation, Canada 2010–2011 Season

(2012) Danuta M. Skowronski et al.   CLINICAL INFECTIOUS DISEASES

Immunodominance of Antigenic Site B over Site A of Hemagglutinin of Recent H3N2 Influenza Viruses

(2012) Lyubov Popova et al.   PLoS One

Serologic assays for influenza surveillance, diagnosis and vaccine evaluation

(2011) Jacqueline M Katz et al.   Expert Review of Anti-Infective Therapy

Neuraminidase Receptor Binding Variants of Human Influenza A(H3N2) Viruses Resulting from Substitution of Aspartic Acid 151 in the Catalytic Site: a Role in Virus Attachment?

(2010) Y. P. Lin et al.   JOURNAL OF VIROLOGY

FastTree 2 – Approximately Maximum-Likelihood Trees for Large Alignments

(2010) Morgan N. Price et al.   PLoS One

Differential neutralization efficiency of hemagglutinin epitopes, antibody interference, and the design of influenza vaccines

(2009) W. Ndifon et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA